Episode 188: Red flags of treatable rare myopathies

This EANcast Weekly Neurology episode delves into the latest advancements in diagnosing and treating rare genetic myopathies and inflammatory myopathies. Experts discuss the evolving diagnostic landscape, from molecular genetic testing to the continued importance of muscle biopsy. They also highlight key clinical red flags to shorten diagnostic delays and explore emerging therapeutic strategies, including gene therapy and novel drug treatments.

Topics in this course: